Lamy, T.; Cabarrou, B.; Planchard, D.; Quantin, X.; Schneider, S.; Bringuier, M.; Besse, B.; Girard, N.; Chouaid, C.; Filleron, T.;
et al. Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience. Cancers 2022, 14, 92.
https://doi.org/10.3390/cancers14010092
AMA Style
Lamy T, Cabarrou B, Planchard D, Quantin X, Schneider S, Bringuier M, Besse B, Girard N, Chouaid C, Filleron T,
et al. Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience. Cancers. 2022; 14(1):92.
https://doi.org/10.3390/cancers14010092
Chicago/Turabian Style
Lamy, Tina, Bastien Cabarrou, David Planchard, Xavier Quantin, Sophie Schneider, Michael Bringuier, Benjamin Besse, Nicolas Girard, Christos Chouaid, Thomas Filleron,
and et al. 2022. "Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience" Cancers 14, no. 1: 92.
https://doi.org/10.3390/cancers14010092
APA Style
Lamy, T., Cabarrou, B., Planchard, D., Quantin, X., Schneider, S., Bringuier, M., Besse, B., Girard, N., Chouaid, C., Filleron, T., Simon, G., & Baldini, C.
(2022). Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience. Cancers, 14(1), 92.
https://doi.org/10.3390/cancers14010092